Bnp Paribas Asset Management Holding S.A. Intellia Therapeutics, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 805 shares of NTLA stock, worth $9,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
805Holding current value
$9,877% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
338Shares Held
96.9MCall Options Held
1.66MPut Options Held
1.03M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$160 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$133 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$118 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.12MShares$50.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.04MShares$49.6 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $933M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...